To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
The New York firm acquires Scientific Protein Laboratories, a maker of ingredients for end-use pharmaceuticals, in its fifth portfolio acquisition for its debut fund, closed last June.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Copyright PEI Media
Not for publication, email or dissemination